P1.15-07 Phase II Study of Pembrolizumab and Itacitinib for First Line Treatment of Metastatic NSCLC Expressing PD-L1.

Details

Language :

English

ISSN :

15560864

Volume :

17

Issue :

9

Database :

Complementary Index

Journal :

Journal of Thoracic Oncology

Publication Type :

Academic Journal

Accession number :

159037449

Full Text :

https://doi.org/10.1016/j.jtho.2022.07.203